Cargando…
Fail-Safe System against Potential Tumorigenicity after Transplantation of iPSC Derivatives
Human induced pluripotent stem cells (iPSCs) are promising in regenerative medicine. However, the risks of teratoma formation and the overgrowth of the transplanted cells continue to be major hurdles that must be overcome. Here, we examined the efficacy of the inducible caspase-9 (iCaspase9) gene as...
Autores principales: | Itakura, Go, Kawabata, Soya, Ando, Miki, Nishiyama, Yuichiro, Sugai, Keiko, Ozaki, Masahiro, Iida, Tsuyoshi, Ookubo, Toshiki, Kojima, Kota, Kashiwagi, Rei, Yasutake, Kaori, Nakauchi, Hiromitsu, Miyoshi, Hiroyuki, Nagoshi, Narihito, Kohyama, Jun, Iwanami, Akio, Matsumoto, Morio, Nakamura, Masaya, Okano, Hideyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355810/ https://www.ncbi.nlm.nih.gov/pubmed/28262544 http://dx.doi.org/10.1016/j.stemcr.2017.02.003 |
Ejemplares similares
-
Low immunogenicity of mouse induced pluripotent stem cell-derived neural stem/progenitor cells
por: Itakura, Go, et al.
Publicado: (2017) -
Pretreatment with a γ-Secretase Inhibitor Prevents Tumor-like Overgrowth in Human iPSC-Derived Transplants for Spinal Cord Injury
por: Okubo, Toshiki, et al.
Publicado: (2016) -
Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell‐Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury
por: Kojima, Kota, et al.
Publicado: (2018) -
Treatment with a Gamma-Secretase Inhibitor Promotes Functional Recovery in Human iPSC- Derived Transplants for Chronic Spinal Cord Injury
por: Okubo, Toshiki, et al.
Publicado: (2018) -
Regenerative therapy for spinal cord injury using iPSC technology
por: Nagoshi, Narihito, et al.
Publicado: (2020)